Tian et al. revealed that, compared to senior NSCLC patients, youth-onset NSCLC patients are more likely to develop ALK fusion mutations and there are more young patients with unusual ALK fusion mutations. The gene discussed is ALK; the disease is non-small cell lung carcinoma.